Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma
Biochemical and Biophysical Research Communications · 2024
DOI: 10.1016/j.bbrc.2024.150421 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2024. Verfasst von Mohan Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Stomatology, Hainan Medical University, Hainan, China. Hauptthemen laut MEDLINE: Tongue Neoplasms, Nuclear Receptor Subfamily 1, Group F, Member 1, Neoplasm Invasiveness, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Hainan Province Natural Science Foundation.
Abstract (Originalsprache)
Retinoic acid receptor-related orphan receptor alpha (RORα), an essential tumor suppressor in a range of human malignancies, is classified as a member of the orphan nuclear receptor family. The most prevalent form of oral cancer, tongue squamous cell carcinoma (TSCC) is characterized by its severe malignancy and unfavorable prognosis. However, the extent to which its tumorigenesis mechanisms are associated with RORα expression levels is still not fully understood. The objective of this study was to examine the molecular mechanisms by which RORα is involved in TSCC. Through the use of immunohistochemistry (IHC), it was discovered that the expression level of RORα was significantly downregulated in TSCC tissues when compared to adjacent normal tissues in this study. To further investigate the role of RORα in TSCC, we activated the expression of RORα in human TSCC cell line (SCC9 cells) by transfecting RORα cDNA and using the selective RORα agonist SR1078. The results show that RORα can significantly inhibit the invasion, migration, proliferation, and adhesion of TSCC cells and induce cell apoptosis. In addition, xenograft models confirmed the conclusion that stable activation or treatment with SR1078 to increase RORα content significantly inhibited tumor growth and development. Taken together, this study provides solid evidence for the inhibitory role of RORα in the progression of TSCC. In addition, the preliminary application results of SR1078 in TSCC show that SR1078 is expected to be a potential therapeutic medication for TSCC. These findings provide innovative perspectives on the development of potential biomarkers and agents for TSCC therapy. The objective is to introduce novel strategy and alternatives for the prevention and treatment of TSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Stomatology, Hainan Medical University, Hainan, China.
- Department of Head and Neck Surgery, Affiliated Cancer Hospital of Hainan Medical University, Hainan, China. Electronic address: yfykqkqy@163.com.
Förderung
- Hainan Province Natural Science Foundation
Zitieren
APA
Wang, M., Zeng, R., Zheng, S., & Qian, Y. (2024). Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2024.150421
Vancouver
Wang M, Zeng R, Zheng S, Qian Y. Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma. Biochemical and Biophysical Research Communications. 2024. doi:10.1016/j.bbrc.2024.150421
BibTeX
@article{Wang2024,
author = {Wang, Mohan and Zeng, Ran and Zheng, Shuang and Qian, Yong},
title = {Retinoic acid receptor-related orphan receptor alpha and synthetic RORα agonist against invasion and metastasis in tongue squamous cell carcinoma},
journal = {Biochemical and Biophysical Research Communications},
year = {2024},
doi = {10.1016/j.bbrc.2024.150421}
}
EUVIMED